|
CIC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.778400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.829700E-02 |
| Normal-vs-Stage2 |
4.008400E-02 |
| Normal-vs-Stage3 |
7.853400E-01 |
| Normal-vs-Stage4 |
1.789020E-01 |
| Stage1-vs-Stage2 |
7.031400E-01 |
| Stage1-vs-Stage3 |
1.084180E-01 |
| Stage1-vs-Stage4 |
9.630800E-01 |
| Stage2-vs-Stage3 |
1.479620E-01 |
| Stage2-vs-Stage4 |
8.389600E-01 |
| Stage3-vs-Stage4 |
3.684000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.567700E-02 |
| Normal-vs-AfricanAmerican |
6.341900E-02 |
| Normal-vs-Asian |
3.432000E-02 |
| Caucasian-vs-AfricanAmerican |
7.011200E-01 |
| Caucasian-vs-Asian |
2.956000E-01 |
| AfricanAmerican-vs-Asian |
3.165200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.752300E-02 |
| Normal-vs-Female |
4.336600E-01 |
| Male-vs-Female |
1.894970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.431700E-02 |
| Normal-vs-Extreme_Weight |
3.589500E-02 |
| Normal-vs-Obese |
9.687400E-01 |
| Normal-vs-Extreme_Obese |
5.353600E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.123800E-01 |
| Normal_Weight-vs-Obese |
4.271800E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.287600E-01 |
| Extreme_Weight-vs-Obese |
2.205800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.840400E-01 |
| Obese-vs-Extreme_Obese |
1.516830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.027000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.572200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.584300E-03 |
| Normal-vs-Age(81-100Yrs) |
2.371600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.625570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.916400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.595700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.644000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.485210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.658800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.751810E-01 |
| Normal-VS-Type2 PRCC |
6.173700E-04 |
| Normal-VS-KIRP CIMP |
3.141000E-01 |
| Normal-VS-Unclassified PRCC |
7.566800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.037500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.867700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.744800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.774200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.114300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.319800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.104400E-03 |
| Normal-vs-N1 |
7.771800E-01 |
| Normal-vs-N2 |
2.573800E-01 |
| N0-vs-N1 |
3.922000E-02 |
| N0-vs-N2 |
2.455800E-02 |
| N1-vs-N2 |
3.359800E-01 |
|
|
